Literature DB >> 6275782

Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.

M W Drulak, A W Chow.   

Abstract

Against 482 obligate anaerobes studied by the agar dilution technique, ceftizoxime was significantly more active than both cefoxitin and cefoperazone (P less than 0.001); the latter two agents were comparable in activity. The enhanced activity of ceftizoxime, as compared with the activity of cefoxitin, was against both gram-positive and gram-negative anaerobes (especially Lactobacillus and bacteroides spp). Cefoperazone, however, was more active than cefoxitin against gram-positive anaerobes (particularly Lactobacillus spp.) but was less active than cefoxitin against gram-negative anaerobes (particularly Bacteroides fragilis and Veillonella spp.).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275782      PMCID: PMC181773          DOI: 10.1128/AAC.20.5.683

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.

Authors:  V L Sutter; A L Barry; T D Wilkins; R J Zabransky
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

2.  Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.

Authors:  R N Jones; P C Fuchs; A L Barry; T L Gavan; E H Gerlach; H M Sommers
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

3.  Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase.

Authors:  H Kojo; M Nishida; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

4.  Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics.

Authors:  D Kaye; W Kobasa; K Kaye
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

5.  Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.

Authors:  N V Jacobus; F P Tally; M Barza; S L Gorbach
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

6.  Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

7.  Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.

Authors:  T Kamimura; Y Matsumoto; N Okada; Y Mine; M Nishida; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

8.  In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.

Authors:  J E Brown; V E Del Bene; C D Collins
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

  8 in total
  15 in total

Review 1.  Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

Authors: 
Journal:  CMAJ       Date:  1990-06-01       Impact factor: 8.262

2.  Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria.

Authors:  M V Borobio; A Pascual; M C Dominguez; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

Review 3.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Modified broth-disk surveillance of clindamycin-resistant Bacteroides fragilis group.

Authors:  F A Zar
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

5.  Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  E D Burgess; A D Blair
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

6.  Propionibacterium acnes osteomyelitis: case report and review of the literature.

Authors:  R C Noble; S B Overman
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

7.  Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.

Authors:  F Lamothe; F Auger; J M Lacroix
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

8.  Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.

Authors:  L Dubreuil; J Devos; C Neut; C Romond
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

9.  Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections.

Authors:  G B Hill; O M Ayers
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

10.  Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.

Authors:  E J Goldstein; D M Citron
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.